Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Fatigue and joint or muscle aches are recognized, relatively common side effects of atorvastatin, though they affect only a minority of people and are usually mild. These symptoms often appear within the first weeks of treatment or after a dose increase, and they frequently improve with time, a lower dose, or a switch to a different statin. However, tiredness and joint pain can also stem from other causes such as vitamin D deficiency, thyroid problems, arthritis, or, rarely, a serious muscle condition that needs prompt attention. There are several important distinctions to consider before assuming your medication is to blame, so see below for the details on warning signs, timing, and when to contact your prescriber.
Because overlapping conditions can mimic statin side effects, a quick, structured review of your symptoms is a smart first step: take a free, instant, online symptom check to see which explanations best fit your situation and get clear guidance on whether to monitor at home, call your doctor, or seek urgent care.
Last reviewed for medical accuracy: 09/12/2026
Atorvastatin is one of the most commonly prescribed medications for lowering cholesterol and reducing cardiovascular risk. Like all medications, it can cause side effects. Patients often ask whether feeling unusually tired or experiencing joint pain is “normal” when taking atorvastatin. Below, we review what clinical studies and authoritative sources tell us about these complaints, offer practical advice, and suggest next steps if you’re concerned.
Atorvastatin belongs to the statin class of drugs. It works by inhibiting an enzyme in the liver (HMG-CoA reductase) that’s necessary for cholesterol production. Lowering “bad” LDL cholesterol helps:
While atorvastatin is generally well tolerated, it does carry a risk of certain atorvastatin side effects, including muscle and joint complaints.
The most frequently noted side effects of atorvastatin, according to the FDA label and large clinical trials, include:
Most side effects are mild to moderate and improve over time or with dose adjustments. Serious reactions, such as liver enzyme elevation or rhabdomyolysis (rare muscle breakdown), are uncommon but warrant prompt medical attention.
While fatigue isn’t the top-listed complaint, some patients do report feeling more tired than usual. Clinical trial data suggest:
Statin-related fatigue may stem from:
Joint pain is reported by approximately 2–3% of patients taking atorvastatin, based on prescribing information and post-marketing surveillance.
Most atorvastatin side effects are mild and resolve on their own. However, certain symptoms should never be ignored:
If you experience any of the above, stop the medication and speak to a doctor immediately.
Your healthcare provider will likely recommend:
Regular check-ins help ensure the drug’s benefits outweigh any discomfort.
If tiredness or joint pain persists, your doctor may consider:
Collaboration with your healthcare team helps find the safest, most effective plan for you.
If you’re unsure about your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you sort through possible causes and prepare for your next medical visit.
Free, online symptom check, using the doctor approved Ubie Symptom Checker
Always remember: never ignore symptoms that feel life threatening or severely impact your quality of life. Speak to a doctor about any concerns, and together you can tailor a treatment plan that balances benefits with potential atorvastatin side effects.
(References)
* Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016 Nov 19;388(10059):2532-2561. doi: 10.1016/S0140-6736(16)31357-5. Epub 2016 Sep 8. PMID: 27616593.
* Ambapkar SN, Shetty N, Dwivedy A. Statin-Induced Rhabdomyolysis. J Assoc Physicians India. 2016 Jul;64(7):93-94. PMID: 27759359.
* HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28. PMID: 28847206.
* Naing C, Ni H. Statins for asthma. Cochrane Database Syst Rev. 2020 Jul 15;7(7):CD013268. doi: 10.1002/14651858.CD013268.pub2. Epub 2020 Jul 15. PMID: 32668027; PMCID: PMC7388183.
* Cai T, Abel L, Langford O, Monaghan G, Aronson JK, Stevens RJ, Lay-Flurrie S, Koshiaris C, McManus RJ, Hobbs FDR, Sheppard JP. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses. BMJ. 2021 Jul 14;374:n1537. doi: 10.1136/bmj.n1537. Epub 2021 Jul 14. PMID: 34261627; PMCID: PMC8279037.
* Zhou S, Chen R, Liu J, Guo Z, Su L, Li Y, Zhang X, Luo F, Gao Q, Lin Y, Pang M, Cao L, Xu X, Nie S. Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin : A Multi-database Cohort Study. Ann Intern Med. 2024 Dec;177(12):1641-1651. doi: 10.7326/M24-0178. Epub 2024 Oct 29. PMID: 39467290.
* Zakyrjanova GF, Matigorova VA, Kuznetsova EA, Dmitrieva SA, Tyapkina OV, Tsentsevitsky AN, Andreyanova SN, Odnoshivkina JG, Shigapova RR, Mukhamedshina YO, Gogolev YV, Petrov AM. Key genes and processes affected by atorvastatin treatment in mouse diaphragm muscle. Arch Toxicol. 2025 Jul;99(7):2877-2901. doi: 10.1007/s00204-025-04056-6. Epub 2025 Apr 16. PMID: 40234311.
* Xu R, Wang X, Gao J, Li Y, Wang S, Li H, Sun B, Dou Z, Hu Y, Zhao T, Liu H, Wang J, Liu Y, Fang X, Sun M, Zhang Y, Han W, Liu X. Identification and evaluation of a lipid-lowering small compound as a PCSK9 inhibitor. J Adv Res. 2026 Aug;86:709-727. doi: 10.1016/j.jare.2025.11.044. Epub 2025 Nov 21. PMID: 41275962; PMCID: PMC13453844.
* Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk, Cholesterol Treatment Trialists' (CTT) Collaboration. Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials. Lancet. 2026 Feb 14;407(10529):689-703. doi: 10.1016/S0140-6736(25)01578-8. Epub 2026 Feb 5. PMID: 41655587; PMCID: PMC7619005.
* Comparison chart: Statins. Med Lett Drugs Ther. 2026 Jun 8;68(1756):e94-e95. doi: 10.58347/tml.2026.1756b. Epub 2026 Jun 8. PMID: 42223921.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.